import streamlit as st
import pandas as pd

st.set_page_config(page_title="References", page_icon="ðŸ“š", layout="wide")



st.title("ðŸ“š References")

st.markdown("""
This page contains comprehensive citations from research literature on lipid nanoparticles, 
nucleic acid delivery, and therapeutic applications.
""")

st.divider()
# Featured Papers
st.header("Featured Papers")
st.info("""
âœ¨ **Featured Research**

1. **Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles.**  
    Brown, D.W., Wee, P., Bhandari, P., et al. *Cell* (2024) 187(19):5357-5375.  
    [DOI: 10.1016/j.cell.2024.07.023](https://doi.org/10.1016/j.cell.2024.07.023)  
    This study presents a novel proteolipid vehicle for the safe and efficient delivery of nucleic acids, demonstrating significant advancements in gene therapy applications.

2. **Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids.**  
    Patel MN, Tiwari S, Wang Y, O'Neill S, Wu J, Omo-Lamai S, Espy C, Chase LS, Majumder A, Hoffman E, Shah A, SÃ¡rkÃ¶zy A, Katzen J, Pardi N, and Brenner JS. *Nature Biotechnology* (2025).  
    [DOI: 10.1038/s41587-025-02556-5](https://doi.org/10.1038/s41587-025-02556-5)  
    This groundbreaking study demonstrates a novel approach to enhancing the safety profile of lipid nanoparticle-mediated DNA delivery through the incorporation of endogenous anti-inflammatory lipids, addressing a critical challenge in non-viral gene therapy.
        
3. **Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery.**  
    Wang, X., Liu, S., Sun, Y., Yu, X., Lee, S.M., Cheng, Q., Wei, T., Gong, J., Robinson, J., Zhang, D. and Lian, X.
    *Nature protocols*, 18(1), pp.265-291, 2023.
    [https://doi.org/10.1038/s41596-022-00755-x](https://doi.org/10.1038/s41596-022-00755-x)
""")

# 2025 References
st.header("2025")
st.markdown("""
1. Rohilla P, Azizoglu E, Park S, Lele A, Prausnitz MR, and Bhamla S. Low-cost, handheld, multi-pulse electroporators for simplified nucleic acid delivery in skin. *Bioeng Transl Med* (2025) e70070. [DOI: 10.1002/btm2.70070](https://doi.org/10.1002/btm2.70070)

2. Rigden DJ and FernÃ¡ndez XM. The 2025 Nucleic Acids Research database issue and the online molecular biology database collection. *Nucleic Acids Res* (2025) 53(D1):D1â€“D9. [DOI: 10.1093/nar/gkae1220](https://doi.org/10.1093/nar/gkae1220)

3. Li H, Liu J, Wang H, Xu C, Shi G, Zhao J, Zhang L, Zeng M, and Jiang L. Biomimetic exosome harnessing exosomal lipidomics and functional proteins for PEDF-pDNA delivery in high altitude pulmonary edema intervention. *J Control Release* (2025) 379:652â€“677. [DOI: 10.1016/j.jconrel.2025.01.033](https://doi.org/10.1016/j.jconrel.2025.01.033)

4. Shariati A, Khezrpour A, Shariati F, Afkhami H, Yarahmadi A, Alavimanesh S, Kamrani S, Modarressi MH, and Khani P. DNA vaccines as promising immuno-therapeutics against cancer: a new insight. *Front Immunol* (2025) 15:1498431. [DOI: 10.3389/fimmu.2024.1498431](https://doi.org/10.3389/fimmu.2024.1498431)

5. Jeon J, Byun H, Lee M, Kim J, Park S, Madrigal-Salazar A, GonzÃ¡lez M, Lopez-Pacheco M, Liu W, Nasr M, Lee S-H, Lee Y-S, Lee L, Kim W-J, Kim D, and Shin S. Exosome-Mediated DNA Delivery for Lung Cancer Therapy. *ACS Applied Materials & Interfaces* (2025) 1944-8252. [DOI: 10.1021/acsami.5c15987](https://doi.org/10.1021/acsami.5c15987)

6. Panda P, Gouda SR, Boxi D, Saha G, and Mohapatra R. Macromolecular Gene Delivery Systems: Advancing Non-viral Therapeutics with Synthetic and Natural Polymers. *J Explor Res Pharmacol* (2025) 10(2):62â€“75. [DOI: 10.14218/JERP.2025.00009](http://dx.doi.org/10.14218/JERP.2025.00009)

7. Konopka EN, Edgerton AO, and Kutzler MA. Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations. *Front Immunol* (2025) 16:1584876. [DOI: 10.3389/fimmu.2025.1584876](https://doi.org/10.3389/fimmu.2025.1584876)

8. Anderluzzi G, Mohamed T, Moschetti G, Del Favero E, Rizzello L, Magnaghi V, FranzÃ© S, and Cilurzo F. The Impact of Using Different Cationic Polymers on the Formation of Efficient Lipopolyplexes for pDNA Delivery. *Int J Nanomedicine* (2025) 20:10021â€“10041. [DOI: 10.2147/IJN.S513568](https://doi.org/10.2147/IJN.S513568)

9. Awlqadr FH, Noreen S, Altemimi AB, Mohammed OA, Qadir SA, Ahmed DH, Alkanan ZT, Tsakali E, Van Impe JFM, Kozak D, Abd El-Maksoud AA, Ashraf MA and Abedelmaksoud TG. Advancement in nanobubble technology: enhancing drug and nutraceutical delivery with focus on bioavailability, targeted therapy, safety, and sustainability. *Front. Nanotechnol.* (2025) 7:1548593. [DOI: 10.3389/fnano.2025.1548593](https://doi.org/10.3389/fnano.2025.1548593)

10. Argenziano M, Spagnolo R, and Cavalli R. What are the future applications of chitosan nanobubbles in drug delivery? *Expert Opinion on Drug Delivery* (2025) 22(3):307â€“309. [DOI: 10.1080/17425247.2025.2462761](https://doi.org/10.1080/17425247.2025.2462761)

11. Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation. *Frontiers in Medical Technology* (2025). [Link](https://www.frontiersin.org/journals/medical-technology/articles/10.3389/fmedt.2025.1591119/full)

12. Safer non-viral DNA delivery using lipid nanoparticles loaded with plasmid DNA. *PMC* (2025). [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC12235526/)
""")

st.divider()

# 2024 References
st.header("2024")
st.markdown("""
1. Li J, Hu J, Jin D, Huo H, Chen N, Lin J, et al. High-throughput synthesis and optimization of ionizable lipids through A3 coupling for efficient mRNA delivery. *J Nanobiotechnol* (2024) 22(1). [DOI: 10.1186/s12951-024-02919-1](https://doi.org/10.1186/s12951-024-02919-1)

2. Development of Polymerâ€“Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection. *ACS Applied Materials & Interfaces* (2024). [DOI: 10.1021/acsami.3c14714](https://doi.org/10.1021/acsami.3c14714)

3. Dual targeted lipid nanoparticles for enhanced DNA delivery. *PubMed* (2024). [PMID: 39988265](https://pubmed.ncbi.nlm.nih.gov/39988265/)

4. Bisen AC, Biswas A, Dubey A, Sanap SN, Agrawal S, Yadav KS, et al. A review on polymers in ocular drug delivery systems. *MedCommâ€“Biomaterials Appl.* (2024) 3(2):e77. [DOI: 10.1002/mba2.77](https://doi.org/10.1002/mba2.77)

5. ÄŒoliÄ‡ M, KraljeviÄ‡ PaveliÄ‡ S, PerÅ¡uriÄ‡ Å½, Agaj A, Bulog A, and PaveliÄ‡ K. Enhancing the bioavailability and activity of natural antioxidants with nanobubbles and nanoparticles. *Redox Rep.* (2024) 29(1):2333619. [DOI: 10.1080/13510002.2024.2333619](https://doi.org/10.1080/13510002.2024.2333619)

6. Chen X, Xu L, Chen C, Huang Q, and Hu J. Recent advances in ultrasound-targeted nanobubbles combined with cancer immunotherapy: mechanisms, applications, and challenges. *Fundam. Res* (2024). [DOI: 10.1016/j.fmre.2024.10.017](https://doi.org/10.1016/j.fmre.2024.10.017)

7. Gattegno R, Arbel L, Riess N, Shinar H, Katz S, and Ilovitsh T. Enhanced capillary delivery with nanobubble-mediated blood-brain barrier opening and advanced high resolution vascular segmentation. *J. Control. Release* (2024) 369:506â€“516. [DOI: 10.1016/j.jconrel.2024.04.001](https://doi.org/10.1016/j.jconrel.2024.04.001)

8. Gul S, Miano TF, Mujeeb A, Chachar M, Majeedano MI, Murtaza G, et al. Advancements in nutraceutical delivery: integrating nanotechnology and microencapsulation for enhanced efficacy and bioavailability. *Matrix Sci. Pharma* (2024) 8:1â€“6. [DOI: 10.4103/mtsp.mtsp_1_24](https://doi.org/10.4103/mtsp.mtsp_1_24)

9. Huang Y, Guo X, Wu Y, Chen X, Feng L, Xie N, et al. Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment. *Signal Transduct. Target. Ther.* (2024) 9(1):34. [DOI: 10.1038/s41392-024-01745-z](https://doi.org/10.1038/s41392-024-01745-z)

10. Kallepalli B, Garg U, Jain N, Nagpal R, Malhotra S, Tiwari T, et al. Intelligent drug delivery: pioneering stimuli-responsive systems to revolutionize disease management- an in-depth exploration. *Curr. drug Deliv.* (2024) 22:195â€“214. [DOI: 10.2174/0115672018278641231221051359](https://doi.org/10.2174/0115672018278641231221051359)

11. Khan MUA, StojanoviÄ† GM, Abdullah MFB, Dolatshahi-Pirouz A, Marei HE, Ashammakhi N, et al. Fundamental properties of smart hydrogels for tissue engineering and applications: a review. *Int J Biol Macromol* (2024) 254:127882. [Link](https://doi.org/10.1016/j.ijbiomac.2024.127882)

12. Kim S, Jeon JH, Kim M, Lee Y, Hwang Y-H, Park M, et al. Innate immune responses against mRNA vaccine promote cellular immunity through IFN-Î² at the injection site. *Nat Commun* (2024) 15:51411. [DOI: 10.1038/s41467-024-51411-9](https://doi.org/10.1038/s41467-024-51411-9)

13. Lei J, Huang D, Zhao W, Liu S, and Yue Y. Investigating the stability mechanisms of single bulk Nanobubbles: a molecular dynamics perspective. *Int. J. Heat Mass Transf.* (2024) 225:125407. [DOI: 10.1016/j.ijheatmasstransfer.2024.125407](https://doi.org/10.1016/j.ijheatmasstransfer.2024.125407)

14. Noreen S, Pervaiz F, Ijaz M, Hanif MF, Hamza JR, Mahmood H, et al. pH-sensitive docetaxel-loaded chitosan/thiolated hyaluronic acid polymeric nanoparticles for colorectal cancer. *Nanomedicine* (2024) 19(9):755â€“777. [DOI: 10.2217/nnm-2023-0318](https://doi.org/10.2217/nnm-2023-0318)

15. Noreen S, and Bernkop-SchnÃ¼rch A. Thiolated poly-and oligosaccharide-based hydrogels for tissue engineering and wound healing. *Adv. Funct. Mater.* (2024) 34(4):2310129. [DOI: 10.1002/adfm.202310129](https://doi.org/10.1002/adfm.202310129)
""")

st.divider()

# 2023 References
st.header("2023")
st.markdown("""

Brown, D.W., Wee, P., Bhandari, P., Bukhari, A., Grin, L., Vega, H., Hejazi, M., Sosnowski, D., Ablack, J., Clancy, E.K. and Pink, D., 2024. Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles. Cell, 187(19), pp.5357-5375. DOI: 10.1016/j.cell.2024.07.023 
            
1. Bai M, Liu Z, Zhan L, Yuan M, and Yu H. Effect of pore size distribution and colloidal fines of porous media on the transport behavior of micro-nano-bubbles. *Colloids Surfaces A Physicochem. Eng. Aspects* (2023) 660:130851. [DOI: 10.1016/j.colsurfa.2022.130851](https://doi.org/10.1016/j.colsurfa.2022.130851)

2. Chakraborty C, Sharma AR, Bhattacharya M, Lee S-S. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape. *Front. Immunol.* (2023) 12:679344. [DOI: 10.3389/fimmu.2021.679344](https://doi.org/10.3389/fimmu.2021.679344)

3. Chang J, Yu BC, Saltzman WM, Girardi M. Nanoparticles as a therapeutic delivery system for skin cancer prevention and treatment. *JID Innovations* (2023) 3(4):100197. [DOI: 10.1016/j.xjidi.2023.100197](https://doi.org/10.1016/j.xjidi.2023.100197)

4. Dasgupta A, Sun T, Palomba R, Rama E, Zhang Y, Power C, et al. Nonspherical ultrasound microbubbles. *Proc. Natl. Acad. Sci. U. S. A.* (2023) 120(13):e2218847120. [DOI: 10.1073/pnas.2218847120](https://doi.org/10.1073/pnas.2218847120)

5. Huang B, Yang L, Yu W, Li Y, Li L, and Gu N. Advances of therapeutic microbubbles and nanobubbles. *Natl. Sci. Open* (2023) 2(5):20220062. [DOI: 10.1360/nso/20220062](https://doi.org/10.1360/nso/20220062)

6. Jain M, Yu X, Schneck JP, Green JJ. Nanoparticle targeting strategies for lipid and polymer-based gene delivery to immune cells *in vivo*. *Small Science* (2023) 4(9):2400248. [DOI: 10.1002/smsc.202400248](https://doi.org/10.1002/smsc.202400248)

7. Javed M, Matloob A, Ettoumi F-e, Sheikh AR, Zhang R, and Xu Y. Novel nanobubble technology in food science: application and mechanism. *Food Innovation Adv.* (2023) 2(2):135â€“144. [DOI: 10.48130/fia-2023-0014](https://doi.org/10.48130/fia-2023-0014)

8. Kancheva M, Aronson L, Pattilachan T, Sautto F, Daines B, Thommes D, et al. Bubble-based drug delivery systems: next-generation diagnosis to therapy. *J. Funct. Biomaterials* (2023) 14(7):373. [DOI: 10.3390/jfb14070373](https://doi.org/10.3390/jfb14070373)

9. Kida H, Yamasaki Y, Feril Jr LB, Endo H, Itaka K, and Tachibana K. Efficient mRNA delivery with lyophilized human serum albumin-based nanobubbles. *Nanomaterials* (2023) 13(7):1283. [DOI: 10.3390/nano13071283](https://doi.org/10.3390/nano13071283)

10. Long J, Yu C, Zhang H, Cao Y, Sang Y, Lu H, Zhang Z, Wang X, Wang H, Song G, Yang J, Wang S. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery. *Adv. Healthc. Mater.* (2023) 12(13):2202590. [DOI: 10.1002/adhm.202202590](https://doi.org/10.1002/adhm.202202590)

11. Messerschmidt V, Ren W, Tsipursky M, and Irudayaraj J. Characterization of oxygen nanobubbles and *in vitro* evaluation of retinal cells in hypoxia. *Transl. Vis. Sci. Technol.* (2023) 12(2):16. [DOI: 10.1167/tvst.12.2.16](https://doi.org/10.1167/tvst.12.2.16)

12. Rando HM, Lordan R, Kolla L, Sell E, Lee AJ, Wellhausen N, et al. The coming of age of nucleic acid vaccines during COVID-19. *mSystems* (2023) 8:e0092822. [DOI: 10.1128/msystems.00928-22](https://doi.org/10.1128/msystems.00928-22)

13. Rhym LH, Manan RS, Koller A, Stephanie G, Anderson DG. Peptide-Encoding mRNA Barcodes for the High-Throughput in Vivo Screening of Libraries of Lipid Nanoparticles for mRNA Delivery. *Nat. Biomed. Eng.* (2023) 7(7):901â€“910. [DOI: 10.1038/s41551-023-01030-4](https://doi.org/10.1038/s41551-023-01030-4)

14. Sarkar N, Bhumiratana S, Geris L, Papantoniou I, Grayson WL. Bioreactors for engineering patient-specific tissue grafts. *Nat Rev Bioeng* (2023) 1(5):361â€“77. [Link](https://doi.org/10.1038/s44222-023-00036-6)

15. Shi X, Ding J, Zheng Y, Wang J, Sobhani N, Neeli P, et al. HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8(+)T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma. *iScience* (2023) 26:106143. [DOI: 10.1016/j.isci.2023.106143](https://doi.org/10.1016/j.isci.2023.106143)

16. Shirane D, Tanaka H, Sakurai Y, Taneichi S, Nakai Y, Tange K, Ishii I, Akita H. Development of an Alcohol Dilutionâ€“Lyophilization Method for the Preparation of mRNA-LNPs with Improved Storage Stability. *Pharmaceutics* (2023) 15(7):1819. [DOI: 10.3390/pharmaceutics15071819](https://doi.org/10.3390/pharmaceutics15071819)

17. Syed Mohamed SMDS, Welsh GI, Roy I. Renal tissue engineering for regenerative medicine using polymers and hydrogels. *Biomater Sci* (2023) 11(17):5706â€“26. [Link](https://doi.org/10.1039/D3BM00375B)

18. Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L. Neoantigens: promising targets for cancer therapy. *Signal Transduct Target Ther* (2023) 8:9. [DOI: 10.1038/s41392-022-01270-x](https://doi.org/10.1038/s41392-022-01270-x)

19. Yang W, Mixich L, Boonstra E, Cabral H. Polymer-based mRNA delivery strategies for advanced therapies. *Adv Healthcare Mater* (2023) 12(15):2202688. [DOI: 10.1002/adhm.202202688](https://doi.org/10.1002/adhm.202202688)

20. Zhang L, Liu Q. mRNA-based vaccines and therapeutics: an in-depth survey of recent advancements. *J Biomed Sci* (2023) 30(1):1â€“16. [DOI: 10.1186/s12929-023-00977-5](https://doi.org/10.1186/s12929-023-00977-5)
""")

st.divider()

# 2022 References
st.header("2022")
st.markdown("""
1. Argenziano M, Occhipinti S, Scomparin A, Angelini C, Novelli F, Soster M, et al. Exploring chitosan-shelled nanobubbles to improve HER2+ immunotherapy via dendritic cell targeting. *Drug Deliv. Transl. Res.* (2022) 12(8):2007â€“2018. [DOI: 10.1007/s13346-022-01185-8](https://doi.org/10.1007/s13346-022-01185-8)

2. Batchelor DV, Armistead FJ, Ingram N, Peyman SA, McLaughlan JR, Coletta PL, et al. The influence of nanobubble size and stability on ultrasound enhanced drug delivery. *Langmuir* (2022) 38(45):13943â€“13954. [DOI: 10.1021/acs.langmuir.2c02303](https://doi.org/10.1021/acs.langmuir.2c02303)

3. Chen Y, Luo X, Liu Y, Zou Y, Yang S, Liu C, et al. Targeted nanobubbles of PD-L1 mAb combined with doxorubicin as a synergistic tumor repressor in hepatocarcinoma. *Int. J. Nanomedicine* (2022) 17:3989â€“4008. [DOI: 10.2147/ijn.s376172](https://doi.org/10.2147/ijn.s376172)

4. Guerrini G, MagrÃ¬ D, Gioria S, Medaglini D, Calzolai L. Characterization of nanoparticles-based vaccines for COVID-19. *Nat Nanotechnol* (2022) 17(6):570â€“6. [DOI: 10.1038/s41565-022-01129-w](https://doi.org/10.1038/s41565-022-01129-w)

5. Henderson MI, Eygeris Y, Jozic A, Herrera M, Sahay G. Leveraging Biological Buffers for Efficient Messenger RNA Delivery via Lipid Nanoparticles. *Mol. Pharmaceutics* (2022) 19(11):4275â€“4285. [DOI: 10.1021/acs.molpharmaceut.2c00587](https://doi.org/10.1021/acs.molpharmaceut.2c00587)

6. Huang P, Deng H, Zhou Y, Chen X. The Roles of Polymers in mRNA Delivery. *Matter* (2022) 5(6):1670â€“1699. [DOI: 10.1016/j.matt.2022.03.006](https://doi.org/10.1016/j.matt.2022.03.006)

7. Jin J, Yang L, Chen F, and Gu N. Drug delivery system based on nanobubbles. *Interdiscip. Mater.* (2022) 1:471â€“494. [DOI: 10.1002/idm2.12050](https://doi.org/10.1002/idm2.12050)

8. Kim J, Jozic A, Lin Y, Eygeris Y, Bloom E, Tan X, Acosta C, MacDonald KD, Welsher KD, Sahay G. Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation. *ACS Nano* (2022) 16(9):14792â€“14806. [DOI: 10.1021/acsnano.2c05647](https://doi.org/10.1021/acsnano.2c05647)

9. Kulkarni AD, Gulecha VS, Dolas R, Zalte AG, Deore SR, Deore SS, et al. Nanobubbles: fundamentals and recent drug delivery applications. *Int. J. Health Sci.* (2022) 1004â€“1025. [DOI: 10.53730/ijhs.v6ns8.11598](https://doi.org/10.53730/ijhs.v6ns8.11598)

10. Li M, Li Y, Li S, Jia L, Wang H, Li M, Deng J, Zhu A, Ma L, Li W, Yu P, Zhu T. The Nano Delivery Systems and Applications of mRNA. *Eur. J. Med. Chem.* (2022) 227:113910. [DOI: 10.1016/j.ejmech.2021.113910](https://doi.org/10.1016/j.ejmech.2021.113910)

11. Muramatsu H, Lam K, Bajusz C, LaczkÃ³ D, KarikÃ³ K, Schreiner P, Martin A, Lutwyche P, Heyes J, Pardi N. Lyophilization Provides Long-Term Stability for a Lipid Nanoparticle-Formulated, Nucleoside-Modified mRNA Vaccine. *Mol. Ther.* (2022) 30(5):1941â€“1951. [DOI: 10.1016/j.ymthe.2022.02.001](https://doi.org/10.1016/j.ymthe.2022.02.001)

12. Nazari S, Hassanzadeh A, He Y, Khoshdast H, and Kowalczuk PB. Recent developments in generation, detection and application of nanobubbles in flotation. *Minerals* (2022) 12(4):462. [DOI: 10.3390/min12040462](https://doi.org/10.3390/min12040462)

13. Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, Zheng Q, Li G, Teng Y, Wu M, Song X. mRNA-Based Therapeutics: Powerful and Versatile Tools to Combat Diseases. *Signal Transduct. Target. Ther.* (2022) 7:166. [DOI: 10.1038/s41392-022-01007-w](https://doi.org/10.1038/s41392-022-01007-w)

14. Richard G, Princiotta MF, Bridon D, Martin WD, Steinberg GD, De Groot AS. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy. *Expert Rev Vaccines* (2022) 21:173â€“84. [DOI: 10.1080/14760584.2022.2012456](https://doi.org/10.1080/14760584.2022.2012456)

15. Skylar-Scott MA, Huang JY, Lu A, Ng AHM, Duenki T, Liu S, et al. Orthogonally induced differentiation of stem cells for the programmatic patterning of vascularized organoids and bioprinted tissues. *Nat Biomed Eng* (2022) 6(4):449â€“62. [Link](https://doi.org/10.1038/s41551-022-00890-4)

16. Yang L, Gong L, Wang P, Zhao X, Zhao F, Zhang Z, Li Y, Huang W. Recent Advances in Lipid Nanoparticles for Delivery of mRNA. *Pharmaceutics* (2022) 14(12):2682. [DOI: 10.3390/pharmaceutics14122682](https://doi.org/10.3390/pharmaceutics14122682)
""")

st.divider()

# 2021 and Earlier References
st.header("2021 and Earlier")
st.markdown("""
### 2021

1. Arshad R, Gulshad L, Haq I-U, Farooq MA, Al-Farga A, Siddique R, et al. Nanotechnology: a novel tool to enhance the bioavailability of micronutrients. *Food Sci. Nutr.* (2021) 9:3354â€“3361. [DOI: 10.1002/fsn3.2311](https://doi.org/10.1002/fsn3.2311)

2. Basu SM, Yadava SK, Singh R, Giri J. Lipid Nanocapsules Co-Encapsulating Paclitaxel and Salinomycin for Eradicating Breast Cancer and Cancer Stem Cells. *Colloids Surf. B Biointerfaces* (2021) 204:111775. [DOI: 10.1016/j.colsurfb.2021.111775](https://doi.org/10.1016/j.colsurfb.2021.111775)

3. Bunkin NF, Shkirin AV, Penkov NV, Goltayev MV, Ignatiev PS, Gudkov SV, et al. Effect of gas type and its pressure on nanobubble generation. *Front. Chem.* (2021) 9:630074. [DOI: 10.3389/fchem.2021.630074](https://doi.org/10.3389/fchem.2021.630074)

4. Chan M-H, Chen W, Li C-H, Fang C-Y, Chang Y-C, Wei D-H, et al. An advanced *in situ* magnetic resonance imaging and ultrasonic theranostics nanocomposite platform: crossing the bloodâ€“brain barrier and improving the suppression of glioblastoma using iron-platinum nanoparticles in nanobubbles. *ACS Appl. Mater. Interfaces* (2021) 13(23):26759â€“26769. [DOI: 10.1021/acsami.1c04990](https://doi.org/10.1021/acsami.1c04990)

5. Deprez J, Lajoinie G, Engelen Y, De Smedt S, and Lentacker I. Opening doors with ultrasound and microbubbles: beating biological barriers to promote drug delivery. *Adv. drug Deliv. Rev.* (2021) 172:9â€“36. [DOI: 10.1016/j.addr.2021.02.015](https://doi.org/10.1016/j.addr.2021.02.015)

6. Favvas EP, Kyzas GZ, Efthimiadou EK, and Mitropoulos AC. Bulk nanobubbles, generation methods and potential applications. *Curr. Opin. Colloid Interface Sci.* (2021) 54:101455. [DOI: 10.1016/j.cocis.2021.101455](https://doi.org/10.1016/j.cocis.2021.101455)

7. Gao Y, Ma Q, Cao J, Shi Y, Wang J, Ma H, et al. Bifunctional alginate/chitosan stabilized perfluorohexane nanodroplets as smart vehicles for ultrasound and pH responsive delivery of anticancer agents. *Int. J. Biol. Macromol.* (2021) 191:1068â€“1078. [DOI: 10.1016/j.ijbiomac.2021.09.166](https://doi.org/10.1016/j.ijbiomac.2021.09.166)

8. Gasca-Salas C, FernÃ¡ndez-RodrÃ­guez B, Pineda-Pardo JA, RodrÃ­guez-Rojas R, Obeso I, HernÃ¡ndez-FernÃ¡ndez F, et al. Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia. *Nat. Commun.* (2021) 12(1):779. [DOI: 10.1038/s41467-021-021022-9](https://doi.org/10.1038/s41467-021-21022-9)

9. Han X, Zhang H, Butowska K, Swingle KL, Alameh M-G, Weissman D, Mitchell MJ. An Ionizable Lipid Toolbox for RNA Delivery. *Nat. Commun.* (2021) 12(1):7233. [DOI: 10.1038/s41467-021-27493-0](https://doi.org/10.1038/s41467-021-27493-0)

10. Ho W, Gao M, Li F, Li Z, Zhang X-Q, Xu X. Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery. *Adv. Healthc. Mater.* (2021) 10(8):2001812. [DOI: 10.1002/adhm.202001812](https://doi.org/10.1002/adhm.202001812)

11. Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. *Nature Revi Mater* (2021) 6(6):1078â€“94. [DOI: 10.1038/s41578-021-00358-0](https://doi.org/10.1038/s41578-021-00358-0)

12. Ji Y, Guo Z, Tan T, Wang Y, Zhang L, Hu J, et al. Generating bulk nanobubbles in alcohol systems. *ACS Omega* (2021) 6(4):2873â€“2881. [DOI: 10.1021/acsomega.0c05222](https://doi.org/10.1021/acsomega.0c05222)

13. Johansen ML, Perera R, Abenojar E, Wang X, Vincent J, Exner AA, et al. Ultrasound-based molecular imaging of tumors with PTPmu biomarker-targeted nanobubble contrast agents. *Int. J. Mol. Sci.* (2021) 22(4):1983. [DOI: 10.3390/ijms220401983](https://doi.org/10.3390/ijms220401983)

14. Liu N, Ye X, Yao B, Zhao M, Wu P, Liu G, et al. Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration. *Bioact Mater* (2021) 6(5):1388â€“401. [Link](https://doi.org/10.1016/j.bioactmat.2020.10.021)

15. Pakbahad AA, Kerr L, Wong DA, Kolios MC, and Tsai SS. Biomedical nanobubbles and opportunities for microfluidics. *RSC Adv.* (2021) 11(52):32750â€“32774. [DOI: 10.1039/d1ra04890b](https://doi.org/10.1039/d1ra04890b)

16. Tanaka M, Chock PB. Oxidative modifications of RNA and its potential roles in biosystem. *Front Mol Biosci* (2021) 8:685331. [DOI: 10.3389/fmolb.2021.685331](https://doi.org/10.3389/fmolb.2021.685331)

17. Tavakoli K, Pour-Aboughadareh A, Kianersi F, Poczai P, Etminan A, Shooshtari L. Applications of CRISPRâ€“Cas9 as an advanced genome editing system in life sciences. *BioTech* (2021) 10(3):14. [Link](https://doi.org/10.3390/biotech10030014)

18. Verbeke R, Lentacker I, De Smedt SC, Dewitte H. The Dawn of mRNA Vaccines: The COVID-19 Case. *J. Controlled Release* (2021) 333:511â€“520. [DOI: 10.1016/j.jconrel.2021.03.043](https://doi.org/10.1016/j.jconrel.2021.03.043)

19. Wojtukiewicz MZ, Rek MM, Karpowicz K, GÃ³rska M, PolityÅ„ska B, Wojtukiewicz AM, et al. Inhibitors of immune checkpointsâ€”PD-1, PD-L1, CTLA-4â€”new opportunities for cancer patients and a new challenge for internists and general practitioners. *Cancer Metastasis Rev* (2021) 40(3):949â€“982. [DOI: 10.1007/s10555-021-09976-0](https://doi.org/10.1007/s10555-021-09976-0)

20. Valsalakumari R, Yadava SK, Szwed M, Pandya AD, MÃ¦landsmo GM, Torgersen ML, Iversen T-G, Skotland T, Sandvig K, Giri J. Mechanism of Cellular Uptake and Cytotoxicity of Paclitaxel Loaded Lipid Nanocapsules in Breast Cancer Cells. *Int. J. Pharm.* (2021) 597:120217. [DOI: 10.1016/j.ijpharm.2021.120217](https://doi.org/10.1016/j.ijpharm.2021.120217)

### 2020

1. Batchelor DV, Abou-Saleh RH, Coletta PL, McLaughlan JR, Peyman SA, and Evans SD. Nested nanobubbles for ultrasound-triggered drug release. *ACS Appl. Mater. Interfaces* (2020) 12(26):29085â€“29093. [DOI: 10.1021/acsami.0c07022](https://doi.org/10.1021/acsami.0c07022)

2. BÃ¶ttger R, Pauli G, Chao P-H, Al Fayez N, Hohenwarter L, Li S-D. Lipid-Based Nanoparticle Technologies for Liver Targeting. *Adv. Drug Delivery Rev.* (2020) 154â€“155:79â€“101. [DOI: 10.1016/j.addr.2020.06.017](https://doi.org/10.1016/j.addr.2020.06.017)

3. Cao Y, Gao GF. mRNA Vaccines: A Matter of Delivery. *EClinicalMedicine* (2020) 32:100746. [DOI: 10.1016/j.eclinm.2021.100746](https://doi.org/10.1016/j.eclinm.2021.100746)

4. Dauba A, Delalande A, Kamimura HA, Conti A, Larrat B, Tsapis N, et al. Recent advances on ultrasound contrast agents for blood-brain barrier opening with focused ultrasound. *Pharmaceutics* (2020) 12(11):1125. [DOI: 10.3390/pharmaceutics12111125](https://doi.org/10.3390/pharmaceutics12111125)

5. Fraire JC, Houthaeve G, Liu J, Raes L, Vermeulen LMP, Stremersch S, et al. Vapor nanobubble is the more reliable photothermal mechanism for inducing endosomal escape of siRNA without disturbing cell homeostasis. *J. Control. Release* (2020) 319:262â€“275. [DOI: 10.1016/j.jconrel.2019.12.050](https://doi.org/10.1016/j.jconrel.2019.12.050)

6. Huang W. T., Chan M. H., Chen X., Hsiao M., and Liu R. S. Theranostic nanobubble encapsulating a plasmon-enhanced upconversion hybrid nanosystem for cancer therapy. *Theranostics* (2020) 10:782â€“796. [DOI: 10.7150/thno.38684](https://doi.org/10.7150/thno.38684)

7. Jackson NAC, Kester KE, Casimiro D, Gurunathan S, DeRosa F. The Promise of mRNA Vaccines: A Biotech and Industrial Perspective. *Npj Vaccines* (2020) 5(1):1â€“6. [DOI: 10.1038/s41541-020-0159-8](https://doi.org/10.1038/s41541-020-0159-8)

8. Kwon H, Mohamed MM, Annable MD, Kim H. Remediation of NAPL-contaminated porous media using micro-nano ozone bubbles: Bench-scale experiments. *J. Contam. Hydrol*. (2020) 228:103563. [Link](https://doi.org/10.1016/j.jconhyd.2019.103563)

9. Lee B. E., Kim H. Y., Kim H.-J., Jeong H., Kim B.-G., Lee H.-E., et al. O-GlcNAcylation regulates dopamine neuron function, survival and degeneration in Parkinson disease. *Brain* (2020) 143(12):3699â€“3716. [DOI: 10.1093/brain/awaa320](https://doi.org/10.1093/brain/awaa320)

10. Mcclements DJ. Nano-enabled personalized nutrition: developing multicomponent-bioactive colloidal delivery systems. *Adv. Colloid Interface Sci.* (2020) 282:102211. [DOI: 10.1016/j.cis.2020.102211](https://doi.org/10.1016/j.cis.2020.102211)

11. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. *Nat Rev Drug Discovery* (2020) 20(1):1â€“24. [DOI: 10.1038/s41573-020-0090-8](https://doi.org/10.1038/s41573-020-0090-8)

12. Neves AR, Sousa A, Faria R, Albuquerque T, Queiroz JA, Costa D. Cancer Gene Therapy Mediated by RALA/Plasmid DNA Vectors: Nitrogen to Phosphate Groups Ratio (N/P) as a Tool for Tunable Transfection Efficiency and Apoptosis. *Colloids Surf. B Biointerfaces* (2020) 185:110610. [DOI: 10.1016/j.colsurfb.2019.110610](https://doi.org/10.1016/j.colsurfb.2019.110610)

13. Polley P, Gupta S, Singh R, Pradhan A, Basu SM, V R, Yadava SK, Giri J. Proteinâ€“Sugar-Glass Nanoparticle Platform for the Development of Sustained-Release Protein Depots by Overcoming Protein Delivery Challenges. *Mol. Pharm.* (2020) 17(1):284â€“300. [DOI: 10.1021/acs.molpharmaceut.9b01022](https://doi.org/10.1021/acs.molpharmaceut.9b01022)

14. Samaridou E, Heyes J, Lutwyche P. Lipid nanoparticles for nucleic acid delivery: current perspectives. *Adv Drug Delivery Rev* (2020) 154â€“5:37â€“63. [DOI: 10.1016/j.addr.2020.06.002](https://doi.org/10.1016/j.addr.2020.06.002)

15. Szwed M, Torgersen ML, Kumari RV, Yadava SK, Pust S, Iversen TG, Skotland T, Giri J, Sandvig K. Biological Response and Cytotoxicity Induced by Lipid Nanocapsules. *J. Nanobiotechnology* (2020) 18(1):5. [DOI: 10.1186/s12951-019-0567-y](https://doi.org/10.1186/s12951-019-0567-y)

16. Tam E, McGrath M, Sladkova M, AlManaie A, Alostaad A, de Peppo GM. Hypothermic and cryogenic preservation of tissue-engineered human bone. *Ann N Y Acad Sci* (2020) 1460(1):77â€“87. [Link](https://doi.org/10.1111/nyas.14178)

17. Yadava SK, Basu SM, Chauhan M, Sharma K, Pradhan A, V R, Giri J. Low Temperature, Easy Scaling Upmethod for Development of Smart Nanostructure Hybrid Lipid Capsulesfor Drug Delivery Application. *Colloids Surf. B Biointerfaces* (2020) 190:110927. [DOI: 10.1016/j.colsurfb.2020.110927](https://doi.org/10.1016/j.colsurfb.2020.110927)

18. Yadava SK, Basu SM, Valsalakumari R, Chauhan M, Singhania M, Giri J. Curcumin-Loaded Nanostructure Hybrid Lipid Capsules for Co-Eradication of Breast Cancer and Cancer Stem Cells with Enhanced Anticancer Efficacy. *ACS Appl. Bio Mater.* (2020) 3:6811. [DOI: 10.1021/acsabm.0c00764](https://doi.org/10.1021/acsabm.0c00764)

### Pre-2020

1. Dolgin E. The Tangled History of mRNA Vaccines. *Nature* (2021) 597(7876):318â€“324. [DOI: 10.1038/d41586-021-02483-w](https://doi.org/10.1038/d41586-021-02483-w)

2. Donahue ND, Acar H, Wilhelm S. Concepts of Nanoparticle Cellular Uptake, Intracellular Trafficking, and Kinetics in Nanomedicine. *Adv. Drug Delivery Rev.* (2019) 143:68â€“96. [DOI: 10.1016/j.addr.2019.04.008](https://doi.org/10.1016/j.addr.2019.04.008)

3. Lee A, Hudson AR, Shiwarski DJ, Tashman JW, Hinton TJ, Yerneni S, et al. 3D bioprinting of collagen to rebuild components of the human heart. *Science* (2019) 365(6452):482â€“7. [Link](https://doi.org/10.1126/science.aav9051)

4. Malone RW, Felgner PL, Verma IM. Cationic liposome-mediated RNA transfection. *Proc Natl Acad Sci USA* (1989) 86(16):6077â€“81. [DOI: 10.1073/pnas.86.16.6077](https://doi.org/10.1073/pnas.86.16.6077)
""")

st.divider()

# Additional Resources
st.header("Additional Resources & Patents")
st.markdown("""
### Patents and Regulatory Documents

1. US20220378700A1 - Lipid Nanoparticles and Formulations Thereof for CAR mRNA Delivery. [Google Patents](https://patents.google.com/patent/US20220378700A1/en)

2. US10507249B2 - Lipid nanoparticle compositions and methods for mRNA delivery. [Google Patents](https://patents.google.com/patent/US10507249B2/en)

3. WO2019246203A1 - Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids. [Google Patents](https://patents.google.com/patent/WO2019246203A1/en)

4. Expedited Programs for Regenerative Medicine Therapies for Serious Conditions. *FDA Guidance*. [FDA Link](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/expedited-programs-regenerative-medicine-therapies-serious-conditions-0)

### Clinical Trials & Market Reports

1. Plasmid DNA Manufacturing Market Poised to Surge to USD 18.11 Billion by 2034 at a Remarkable 21.05% CAGR. *BioSpace* (2024). [Link](https://www.biospace.com/press-releases/plasmid-dna-manufacturing-market-poised-to-surge-to-usd-18-11-billion-by-2034-at-a-remarkable-21-05-cagr)

2. U.S. Plasmid DNA Manufacturing Market Size Report, 2033. *Grand View Research*. [Link](https://www.grandviewresearch.com/industry-analysis/us-plasmid-dna-manufacturing-market-report)

3. Regenerative Medicine Therapy Clinical Trials. *Mayo Clinic Research*. [Link](https://www.mayo.edu/research/clinical-trials/tests-procedures/regenerative-medicine-therapy)

### Review Articles

1. Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer. *PMC* (2024). [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC12474387/)

2. The future of cancer immunotherapy: DNA vaccines leading the way. *PMC* (2023). [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC10251337/)

3. The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects. *Frontiers in Immunology* (2024). [Link](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1332939/full)

4. Hybrid Lipid Nanocapsules: A Robust Platform for mRNA Delivery. *PMC - NIH*. [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC10995897/)

5. Physical methods of nucleic acid transfer: general concepts and applications. *PMC - NIH*. [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC2697808/)

6. Technical Improvement and Application of Hydrodynamic Gene Delivery in Study of Liver Diseases. *Frontiers in Pharmacology*. [Link](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00591/full)

7. Hydrodynamic Delivery: Characteristics, Applications, and Technological Advances. *MDPI Pharmaceutics*. [Link](https://www.mdpi.com/1999-4923/15/4/1111)

8. Plasmid DNA Delivery into the Skin via Electroporation with a Depot-Type Electrode. *MDPI Pharmaceutics* (2024). [Link](https://www.mdpi.com/1999-4923/16/9/1219)

9. Microbubbleâ€“Nanoparticle Complexes for Ultrasound-Enhanced Cargo Delivery. *PMC*. [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC9698658/)

10. Microbubbles and Nanobubbles with Ultrasound for Systemic Gene Delivery. *MDPI Pharmaceutics*. [Link](https://www.mdpi.com/1999-4923/12/10/964)

11. The Interface of Gene Editing with Regenerative Medicine. *PMC - PubMed Central*. [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC12382428/)
""")

st.divider()

st.info("""
ðŸ’¡ **Note**: This reference list is continuously updated to include the latest research in lipid nanoparticle 
technology, nucleic acid delivery, and therapeutic applications. All citations include DOI links where available 
for direct access to the original publications.
""")
